Symptomatic VTE · ambulatory cancer patients receiving chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major bleeding · ambulatory cancer patients receiving chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic PE · ambulatory cancer patients receiving chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic DVT · ambulatory cancer patients receiving chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total VTE · ambulatory cancer patients receiving chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
1‐year overall mortality · ambulatory cancer patients receiving chemotherapy
Unfractionated heparin showed no clear difference in 1‐year overall mortality compared with no thromboprophylaxis (moderate certainty).
1 finding from 1 review
Clinically relevant bleeding · ambulatory cancer patients receiving chemotherapy
Unfractionated heparin showed no clear difference in clinically relevant bleeding compared with no thromboprophylaxis (low certainty).
1 finding from 1 review
Success rate of replantation1 (analysed by participant) · patients undergoing digital replantation after traumatic amputation
It is very uncertain whether low molecular weight heparin changes success rate of replantation1 (analysed by participant, compared with unfractionated heparin (very low certainty).
1 finding from 1 review
Success rate of replantation1 (analysed by digit, · patients undergoing digital replantation after traumatic amputation
Low molecular weight heparin showed no clear difference in success rate of replantation1 (analysed by digit, compared with unfractionated heparin (low certainty).
1 finding from 1 review
Incidence of compromised microcirculation requiring invasive intervention (re‐exploration) (analysed by digit, · patients undergoing digital replantation after traumatic amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of compromised microcirculation requiring invasive intervention (incision) (analysed by participant/digit, · patients undergoing digital replantation after traumatic amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Microvascular insufficiency due to vessel occlusion ‐ arterial occlusion (analysed by digit, · patients undergoing digital replantation after traumatic amputation
It is very uncertain whether low molecular weight heparin changes microvascular insufficiency due to vessel occlusion ‐ arterial… compared with unfractionated heparin (very low certainty).
1 finding from 1 review
Microvascular insufficiency due to vessel occlusion ‐ venous occlusion (analysed by participant, · patients undergoing digital replantation after traumatic amputation
It is very uncertain whether low molecular weight heparin changes microvascular insufficiency due to vessel occlusion ‐ venous… compared with unfractionated heparin (very low certainty).
1 finding from 1 review
Complication and adverse reactions ‐ wound bleeding (analysed by participant, · patients undergoing digital replantation after traumatic amputation
Low molecular weight heparin showed no clear difference in complication and adverse reactions ‐ wound bleeding (analysed by… compared with unfractionated heparin (low certainty).
1 finding from 1 review
Intervention not reported
Additional side effects of heparin · children with congenital heart disease undergoing CC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Heparin‐induced thrombocytopenia (HIT) · people undergoing surgical procedures and treated with UFH or LMWH for prophylaxis of thrombotic events lasting at least 5 days
The intervention may leads to lower heparin‐induced thrombocytopenia (HIT) (low certainty).
1 finding from 1 review
Intervention not reported
Arterial thrombotic events (6 to 48 hours after CC) · children with congenital heart disease undergoing CC
The intervention showed no clear difference in arterial thrombotic events (6 to 48 hours after CC) (moderate certainty).
1 finding from 1 review
Intervention not reported
Major bleeding events (timing not specified) · children with congenital heart disease undergoing CC
The intervention showed no clear difference in major bleeding events (timing not specified) (moderate certainty).
1 finding from 1 review
Intervention not reported
Minor bleeding events (timing not specified) · children with congenital heart disease undergoing CC
The intervention showed no clear difference in minor bleeding events (timing not specified) (moderate certainty).
1 finding from 1 review
Intervention not reported
Other thrombotic events: venous thrombosis (up to 48 hours after CC) · children with congenital heart disease undergoing CC
The intervention showed no clear difference in other thrombotic events: venous thrombosis (up to 48 hours after CC) (moderate certainty).
1 finding from 1 review